BioCentury | Oct 22, 2012
Clinical News

Recilisib sodium: Phase I data

...San Juan. Onconova Therapeutics Inc. , Newton, Pa. Product: Recilisib sodium ( Oral Ex-RAD ) ( ON 01210.Na...
BioCentury | Oct 22, 2012
Clinical News

Recilisib sodium: Phase I data

...A placebo-controlled Phase I trial in 32 healthy volunteers showed that 50-300 mg doses of subcutaneous Ex-RAD...
...in San Juan. Onconova Therapeutics Inc. , Newton, Pa. Product: Recilisib sodium ( Subcutaneous Ex-RAD ) ( ON 01210.Na...
BioCentury | Oct 22, 2012
Clinical News

Recilisib sodium: Phase I data

...trial in 20 healthy volunteers showed that a 2-dose regimen of 200 and 400 mg subcutaneous Ex-RAD...
...in San Juan. Onconova Therapeutics Inc. , Newton, Pa. Product: Recilisib sodium ( Subcutaneous Ex-RAD ) ( ON 01210.Na...
BioCentury | Jan 26, 2009
Clinical News

Onconova Therapeutics preclinical data

...When pre-treated at 24 hours and 15 minutes with 500 mg/kg of subcutaneous Ex-RAD, significantly more mice...
...radioprotectant that modulates DNA repair pathways. Onconova Therapeutics Inc. , Princeton, N.J. Product: Ex-RAD ( ON 01210.Na...
BioCentury | Jan 26, 2009
Clinical News

Ex-RAD: Phase I started

...Ex-RAD 001 trial in healthy volunteers. Onconova Therapeutics Inc. , Princeton, N.J. Product: Ex-RAD ( ON 01210.Na...
Items per page:
1 - 5 of 5